RxDoctor Payments Data

Miriam Shatley, MD

Dermatology · Flowood, MSNPI 1235154121

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.2% of the total across 490 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 32 manufacturers reported payments, led by AbbVie at 25.8% of the total.

$9,169in general payments, 2019–2025

Across 490 payments — averaging $18.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Novartis$1K
  • Pfizer$801
  • Lilly USA, LLC$545
  • Johnson & Johnson$426
  • Regeneron Healthcare Solutions, Inc.$426
  • plus $3K from 26 others

What the payments were for

  • Food & beverage$8,91297%
  • Education$2573%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,169 in reported general payments places this provider in the 70th percentile of 78 dermatology providers in Mississippi.

See all dermatology providers in Mississippi

Medicare billing

Part B allowed, 2024
$183,337
Medicare patients
1,111
Services billed
3,085

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent SyringeDupilumab13$48,356
Clobetasol Propionate37$3,765
Triamcinolone Acetonide190$2,434
Hydroxychloroquine Sulfate46$1,584
Ketoconazole81$996
Hydrocortisone80$691
Fluocinonide21$624
Doxycycline Hyclate52$607
Metronidazole14$563
Minoxidil63$501
MethotrexateMethotrexate Sodium11$395
Fluconazole50$383
Mupirocin38$262
Azathioprine11$256
Celecoxib11$168

Paid to pharmacies, not to this prescriber.

Other dermatology in Flowood

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →